Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 241 publications

Strategies for Switching between Oral Postsynaptic Antidopaminergic Antipsychotics in Patients with Schizophrenia: A Systematic Review.

Strategies for Switching between Oral Postsynaptic Antidopaminergic Antipsychotics in Patients with Schizophrenia: A Systematic Review.

Journal: CNS drugs
Published: June 26, 2025

Antipsychotic-Related Prolactin Changes: A Systematic Review and Dose-Response Meta-analysis.

Antipsychotic-Related Prolactin Changes: A Systematic Review and Dose-Response Meta-analysis.

Journal: CNS drugs
Published: May 12, 2025

Sexual dysfunctions related to use of antipsychotics: A protocol for a systematic review and meta-analysis.

Sexual dysfunctions related to use of antipsychotics: A protocol for a systematic review and meta-analysis.

Journal: PloS one
Published: February 11, 2025

Lurasidone versus typical antipsychotics for schizophrenia.

Lurasidone versus typical antipsychotics for schizophrenia.

Journal: The Cochrane database of systematic reviews
Published: January 20, 2025

An Evaluation of Iloperidone for Mania in Bipolar I Disorder.

An Evaluation of Iloperidone for Mania in Bipolar I Disorder.

Journal: The Annals of pharmacotherapy
Published: January 13, 2025

Third-Generation Antipsychotics: The Quest for the Key to Neurotrophism.

Third-Generation Antipsychotics: The Quest for the Key to Neurotrophism.

Journal: Life (Basel, Switzerland)
Published: December 27, 2024

Correction: Danek, P.J.; Daniel, W.A. Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms. Cells 2021, 10, 3472.

Correction: Danek, P.J.; Daniel, W.A. Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms. Cells 2021, 10, 3472.

Journal: Cells
Published: December 12, 2024

Antipsychotic drug dosing and study discontinuation in schizophrenia: A systematic review and dose-response meta-analysis.

Antipsychotic drug dosing and study discontinuation in schizophrenia: A systematic review and dose-response meta-analysis.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: December 03, 2024

Antipsychotic drug dosing and study discontinuation in schizophrenia: A systematic review and dose-response meta-analysis.

Antipsychotic drug dosing and study discontinuation in schizophrenia: A systematic review and dose-response meta-analysis.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: December 03, 2024

An Updated Safety Review of the Relationship Between Atypical Antipsychotic Drugs, the QTc Interval and Torsades de Pointe As: Implications for Clinical Use.

An Updated Safety Review of the Relationship Between Atypical Antipsychotic Drugs, the QTc Interval and Torsades de Pointe As: Implications for Clinical Use.

Journal: Expert opinion on drug safety
Published: August 10, 2024

Iloperidone (Fanapt) - a new indication for bipolar disorder.

Iloperidone (Fanapt) - a new indication for bipolar disorder.

Journal: The Medical letter on drugs and therapeutics
Published: July 15, 2024

Systematic Approach in the Development of Chitosan Functionalized Iloperidone Nanoemulsions for Transnasal Delivery, In Vitro and In Vivo Studies.

Systematic Approach in the Development of Chitosan Functionalized Iloperidone Nanoemulsions for Transnasal Delivery, In Vitro and In Vivo Studies.

Journal: AAPS PharmSciTech
Published: June 21, 2024
Showing 1-12 of 241

Last Updated: 10/31/2025